Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New MRI software aims to cut scan time and noise

NCT ID NCT07167953

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jul 02, 2026 · Updated 3 times

Summary

This study tests new computer software for brain MRI scans that could make them faster, quieter, and produce clearer images. About 131 adults, including healthy volunteers and patients already scheduled for a brain MRI, will have one 60-minute scan. Researchers will compare standard scans with the new spiral technique to see if it improves image quality and reduces scan time.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
spiral MRI software
What this could lead to
If successful, this could make brain MRI scans faster, quieter, and easier to interpret, improving patient comfort and clinic efficiency.
What could go wrong
This is an early-stage, non-randomized study focused on image quality, not diagnosis or treatment. The new software may not work as well in real-world settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 131 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Aug 2028

An estimate. Start dates often move.

Expected to finish

May 2031

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Healthy Controls Inclusion Criteria: * Adults at least 18 years * Able to provide written informed consent on their own behalf Brain MR Inclusion Criteria: * Adults at least 18 years * Able to provide written informed consent on their own behalf * Scheduled for standard of care brain MRI Exclusion Criteria (ALL): * Unable or unwilling to provide informed consent * Contraindication(s) to or inability to undergo MRI * Currently pregnant * Participants requiring intravenous (IV) conscious sedation for imaging are not eligible; participants requiring mild, oral anxiolytics for the clinical MRI will be allowed as long as the following criteria are met: * participant has their own prescription for the medication * informed consent process is conducted prior to the self-administration of the medication * they come to the research visit with a driver

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Brain mri are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • University of Wisconsin - Madison

    Madison, Wisconsin, 53705, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.